全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage

DOI: 10.1177/1753944717745494

Keywords: angiogenesis, arteriogenesis, chronic limb-threatening ischemia, growth hormone, neuropathic response, redox balance, wound healing

Full-Text   Cite this paper   Add to My Lib

Abstract:

Revascularization for chronic limb-threatening ischemia (CLTI) is necessary to alleviate symptoms and wound healing. When it fails or is not possible, there are few alternatives to avoid limb amputation in these patients. Although experimental studies with stem cells and growth factors have shown promise, clinical trials have demonstrated inconsistent results because CLTI patients generally need arteriogenesis rather than angiogenesis. Moreover, in addition to the perfusion of the limb, there is the need to improve the neuropathic response for wound healing, especially in diabetic patients. Growth hormone (GH) is a pleiotropic hormone capable of boosting the aforementioned processes and adds special benefits for the redox balance. This hormone has the potential to mitigate symptoms in ischemic patients with no other options and improves the cardiovascular complications associated with the disease. Here, we discuss the pros and cons of using GH in such patients, focus on its effects on peripheral arteries, and analyze the possible benefits of treating CLTI with this hormone

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133